Objective: to explore the role of intestinal endotoxemia (IETM) in the occurrence and development of nonalcoholic steatohepatitis (NASH).
目的:探讨肠源性内毒素血癥(IETM)在非酒精性脂肪性肝炎(NASH)发生发展中的作用。
The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis.
非酒精性脂肪性肝炎和其他脂肪性肝病的发病机制:四步模型,包括肝硬化进展的脂质释放和肝微梗阻的作用。
Fatty liver disease can take many forms that vary in severity, with the most severe being nonalcoholic steatohepatitis (NASH), fibrosis and cirrhosis. NAFLD can lead to liver failure.
脂肪性肝病恶化后会很复杂,最严重的是非酒精性脂肪肝炎、肝纤维化、肝硬化。非酒精性脂肪肝会导致肝功能衰竭。
The condition can cause hyperlipidemia and weight gain and may play a role in the development of nonalcoholic steatohepatitis which can progress to more severe liver disease.
甲状腺功能低下可以引起高脂血癥和体重增加而且可能在非酒精性脂肪性肝炎形成过程中发挥重要作用,更进一步发展成更严重的肝脏疾病。
Fatty liver disease can take many forms that vary in severity, with the most severe being nonalcoholic steatohepatitis (NASH), fibrosis and cirrhosis.
脂肪性肝病恶化后会很复杂,最严重的是非酒精性脂肪肝炎、肝纤维化、肝硬化。
Should combination therapy be the paradigm for future nonalcoholic steatohepatitis clinical trials?
联合治疗应是未来非酒精性脂肪性肝炎临床试验的范例吗?
The new study included 55 people with nonalcoholic steatohepatitis and either insulin resistance or type 2 diabetes.
新的研究包括55个患非酒精性脂肪性肝炎且有胰岛素抵抗或2型糖尿病的患者。